Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Columbia University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Columbia University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Columbia University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Columbia University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Columbia University, Medical Devices Deals, 2011 to YTD 2017 11
Columbia University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Columbia University, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 14
Atossa Genetics Enters into Agreement with Columbia University Medical Center 15
Biogen Idec Enters into Research Agreement with Columbia University Medical Center 16
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 17
CSPC ZhongQi Pharma to Enter into Co-Development Agreement with Columbia University 18
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 19
Sanofi-aventis Enters Into Research Collaboration With Columbia University 20
Licensing Agreements 21
Lin Bioscience Enters into Licensing Agreement with Columbia University and Memorial Sloan Kettering Cancer Center 21
Lin Bioscience Enters into Licensing Agreement with Columbia Technology Ventures 22
Fortress Biotech Enters into Licensing Agreement with Columbia University 23
Heat Biologics Enters into Licensing Agreement with Columbia University 24
vTv Therapeutics Enters into Licensing Agreement with Columbia University 25
ALSP Enters Into Licensing Agreement with Columbia University 26
iCura Vision Enters into Licensing Agreement with Columbia Technology Ventures 27
Sapience Therapeutics Enters into Licensing Agreement with Columbia University 28
Vor BioPharma Enters into Licensing Agreement with Columbia University 29
Apeiron Biologics Enters into Licensing Agreement with Columbia University 30
Kyras Therapeutics Enters into Agreement with Columbia University 31
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University 32
China Institute of Strategy and Management Lanmeng Investment Enters Into Licensing Agreement With Columbia University 33
Columbia University Enters Into Licensing Agreement With Alkeus Pharma 34
Columbia University – Key Competitors 35
Columbia University – Key Employees 36
Columbia University – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 39
Government and Public Interest 39
Nov 16, 2017: Irving Family’s $700 Million Bequest to Columbia University and NewYork-Presbyterian Sets Stage for Dramatic Advances in Cancer Research and Care 39
Nov 08, 2017: Mechanical heart valve often the safest choice 41
Oct 16, 2017: Cancer Researchers at Wake Forest Baptist Receive $9 Million Grant to Study Aggressive Brain Cancer 43
Oct 02, 2017: DSI Professor Conducts Research to Combat Pancreatic Cancer 44
Sep 27, 2017: NIH announces centers for myalgic encephalomyelitis/chronic fatigue syndrome research 45
Sep 27, 2017: NIH Awards $9.6 Million Grant to Columbia for a Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Collaborative Research Center 47
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 49
Jul 18, 2016: Toxic Alzheimer’s Protein Spreads Through Brain Via Extracellular Space 51
Jul 14, 2016: Columbia University Awarded $58.4 Million to Accelerate Development of New Therapies 52
Apr 21, 2016: Columbia Engineering-led Team Advances Single Molecule Electronic DNA Sequencing—A Future Platform for Precision Medicine 54
Feb 17, 2016: Cancer Study is ‘Paradigm Shift’ in Cause of Tumor Formation 56
Jan 21, 2016: Columbia Neuroscientists Develop New Tools to Safely Trace Brain Circuits 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58
Columbia University, Pharmaceuticals & Healthcare, Key Facts 2
Columbia University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Columbia University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Columbia University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Columbia University, Deals By Therapy Area, 2011 to YTD 2017 9
Columbia University, Medical Devices Deals, 2011 to YTD 2017 11
Columbia University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 14
Atossa Genetics Enters into Agreement with Columbia University Medical Center 15
Biogen Idec Enters into Research Agreement with Columbia University Medical Center 16
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 17
CSPC ZhongQi Pharma to Enter into Co-Development Agreement with Columbia University 18
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 19
Sanofi-aventis Enters Into Research Collaboration With Columbia University 20
Lin Bioscience Enters into Licensing Agreement with Columbia University and Memorial Sloan Kettering Cancer Center 21
Lin Bioscience Enters into Licensing Agreement with Columbia Technology Ventures 22
Fortress Biotech Enters into Licensing Agreement with Columbia University 23
Heat Biologics Enters into Licensing Agreement with Columbia University 24
vTv Therapeutics Enters into Licensing Agreement with Columbia University 25
ALSP Enters Into Licensing Agreement with Columbia University 26
iCura Vision Enters into Licensing Agreement with Columbia Technology Ventures 27
Sapience Therapeutics Enters into Licensing Agreement with Columbia University 28
Vor BioPharma Enters into Licensing Agreement with Columbia University 29
Apeiron Biologics Enters into Licensing Agreement with Columbia University 30
Kyras Therapeutics Enters into Agreement with Columbia University 31
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University 32
China Institute of Strategy and Management Lanmeng Investment Enters Into Licensing Agreement With Columbia University 33
Columbia University Enters Into Licensing Agreement With Alkeus Pharma 34
Columbia University, Key Competitors 35
Columbia University, Key Employees 36
Columbia University, Subsidiaries 37